相关实验视频

Updated: Mar 4, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

可变形的尖聚可通过有条件的抗原捕获和STING激活在现场进行癌症疫苗接种

Chenglong Ge¹, Fan Wu¹, Xinke Zhang^2,3

¹Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.

Journal of the American Chemical Society

|March 2, 2026

概括

一种新型的自我辅助疫苗前体在瘤微环境中转化,捕获抗原并激活STING. 这种在位癌症疫苗通过产生强大的抗瘤免疫反应,有效地抑制瘤生长和复发.

科学领域:

生物材料科学生物材料科学
免疫学免疫学免疫学
纳米技术纳米技术

背景情况:

自主瘤抗原癌症疫苗显示出免疫治疗的前景.
目前的疫苗在抗原捕获效率和癌症选择性免疫激活方面面临挑战.

研究的目的:

开发一种自我辅助的疫苗前体,形成一种在位癌症疫苗.
为条件抗原捕获和STING激活设计形状可变聚.

主要方法:

构造的半孔纳米颗粒 (MSN) 封装有梅利,并装饰有DMXAA结合的多.
利用瘤微环境中的多的构造转化来触发梅利释放和抗原捕获.
通过多价值DMXAA显示实现了STING (干扰素基因刺激器) 激活.

主要成果:

疫苗前体采用了休眠的,灵活的形状,防止过早的抗原捕获.
在酸性瘤微环境中,聚类形成了刚性螺旋结构,释放梅利来杀死癌细胞并产生抗原.
现场纳米疫苗证明了有效的抗原捕获和STING激活,从而产生强大的抗瘤免疫力.
在携带B16F10瘤的小鼠中观察到显著抑制瘤生长和复发.

结论:

开发了一种可变形,自我辅助的疫苗前体,用于现场癌症疫苗接种.
展示了一种新的设计策略,控制聚合物构成,以调节生物宏分子相互作用.
这种方法为个性化癌症疫苗开发提供了一个有希望的范式.

更多相关视频

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Vaccinations

Vaccinations

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...